WiseBuzz announced on the 18th that it is establishing a dedicated team for US Direct‑to‑Consumer (DTC) advertising. The move aims to assist Korean pharmaceutical, biotech and healthcare companies in entering the US market.
DTC advertising allows companies to promote prescription drugs, medical devices and other health products directly to consumers. The United States is one of the few markets where prescription‑drug advertising to the general public is permitted, and several Korean firms already use DTC campaigns after expanding into the US.
WiseBuzz plans to run the DTC business as a core service, providing expertise and resources for Korean firms seeking to build brand awareness among US consumers.
AnalysisAug 30, 2026•1 min read
WiseBuzz Forms US DTC Advertising Team to Support Korean Pharma Expansion
WiseBuzz announced the creation of a dedicated US Direct‑to‑Consumer advertising team to help Korean pharma and biotech firms launch DTC campaigns in the United States.
Compiled by the PharmaCountry team · Source: KPA News
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating